These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19900216)

  • 1. Mutant presenilin-1 deregulated peripheral immunity exacerbates Alzheimer-like pathology.
    Zhu Y; Obregon D; Hou H; Giunta B; Ehrhart J; Fernandez F; Mori T; Nikolic W; Zhao Y; Morgan D; Town T; Tan J
    J Cell Mol Med; 2011 Feb; 15(2):327-38. PubMed ID: 19900216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ effector T cells accelerate Alzheimer's disease in mice.
    Machhi J; Yeapuri P; Lu Y; Foster E; Chikhale R; Herskovitz J; Namminga KL; Olson KE; Abdelmoaty MM; Gao J; Quadros RM; Kiyota T; Jingjing L; Kevadiya BD; Wang X; Liu Y; Poluektova LY; Gurumurthy CB; Mosley RL; Gendelman HE
    J Neuroinflammation; 2021 Nov; 18(1):272. PubMed ID: 34798897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
    Puig KL; Kulas JA; Franklin W; Rakoczy SG; Taglialatela G; Brown-Borg HM; Combs CK
    Neurobiol Aging; 2016 Apr; 40():22-40. PubMed ID: 26973101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
    Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
    Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
    Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
    Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss.
    Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T
    Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.
    Lee J; Chan SL; Mattson MP
    Neuromolecular Med; 2002; 2(1):29-45. PubMed ID: 12230303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
    J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.
    Holcomb L; Gordon MN; McGowan E; Yu X; Benkovic S; Jantzen P; Wright K; Saad I; Mueller R; Morgan D; Sanders S; Zehr C; O'Campo K; Hardy J; Prada CM; Eckman C; Younkin S; Hsiao K; Duff K
    Nat Med; 1998 Jan; 4(1):97-100. PubMed ID: 9427614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice.
    Luo G; Xu H; Huang Y; Mo D; Song L; Jia B; Wang B; Jin Z; Miao Z
    Biomed Res Int; 2016; 2016():8380618. PubMed ID: 27294139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.
    Agca C; Klakotskaia D; Schachtman TR; Chan AW; Lah JJ; Agca Y
    BMC Neurosci; 2016 Jul; 17(1):46. PubMed ID: 27388605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
    Griciuc A; Federico AN; Natasan J; Forte AM; McGinty D; Nguyen H; Volak A; LeRoy S; Gandhi S; Lerner EP; Hudry E; Tanzi RE; Maguire CA
    Hum Mol Genet; 2020 Oct; 29(17):2920-2935. PubMed ID: 32803224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity.
    Heilig EA; Xia W; Shen J; Kelleher RJ
    J Biol Chem; 2010 Jul; 285(29):22350-9. PubMed ID: 20460383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.